Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 53, 4499-4504, October 1, 1993]
© 1993 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magnuson, B. A.
Right arrow Articles by Bird, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magnuson, B. A.
Right arrow Articles by Bird, R. P.

Ability of Aberrant Crypt Foci Characteristics to Predict Colonic Tumor Incidence in Rats Fed Cholic Acid1

Bernadene A. Magnuson, Ian Carr and Ranjana P. Bird2

Departments of Foods and Nutrition [B. A. M., R. P. B.], and Pathology [I. C.], University of Manitoba, Winnipeg, Manitoba, R3T 2N2 Canada

2 To whom requests for reprints should be addressed.

Aberrant crypt foci (ACF) are putative preneoplastic lesions of colon cancer which are being utilized currently as a biological end point to evaluate the induction and modulation of colon carcinogenesis. In several previous short-term studies, the unexpected reduction of ACF by the reported colonic tumor promoter cholic acid (CHA) emphasized the need for a systematic evaluation of the growth of ACF in response to a tumor promoter.

The present study was conducted to determine if any characteristic(s) of ACF at various early stages of carcinogenesis would predict resulting tumor incidence in rats fed CHA. Male Sprague-Dawley rats received two injections of azoxymethane (20 mg/kg) and were fed either the AIN-76 diet or AIN-76 plus 0.2% CHA. The number, crypt multiplicity (number of crypts/focus), and size (area) of ACF were measured after 2, 8,14, and 18 weeks in 5 rats/group. The number of ACF was lower (P < 0.033) in animals fed CHA at all time points. Average crypt multiplicity of ACF was greater (P = 0.045) from CHA-fed animals after 8 weeks compared to animals fed the AIN-76 diet. The average size of ACF was smaller in CHA-fed animals after 2 weeks and then tended to be larger than the sizes of the ACF from animals fed the AIN-76 diet. All remaining animals were killed after 18 weeks. Tumor incidence was higher (P < 0.001) in the CHA-fed group (63.2%) compared to the control diet group (29.4%). CHA-fed rats also had a higher number of tumors/tumor-bearing rat compared to control diet rats (1.96 versus 1.13). The main finding of this study is that the number of ACF at early time points did not predict tumor incidence. Crypt multiplicity was a consistent predictor of tumor outcome and should be measured in future studies using ACF as a biological end point. The CHA diet appears to provide a unique tumor-modulating environment that selectively enhances the growth of a smaller number of ACF leading to an increased number of tumors compared to a control diet. The mechanism(s) by which CHA mediates this effect warrants further investigation.

1 Funded by the National Cancer Institute of Canada and The Natural Sciences and Engineering Research Council to R. R B. B. A. M. is the recipient of a Manitoba Health Research Council Studentship. R. R B. is a recipient of a Women in Science Career Award of the Natural Sciences and Engineering Research Council. Presented in part at the Canadian Federation of Biological Societies 35th Annual Meeting, Victoria, British Columbia, Canada, June 18, 1992.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 10/20/92. Accepted 7/26/93.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
I. Winkelmann, D. Diehl, D. Oesterle, H. Daniel, and U. Wenzel
The suppression of aberrant crypt multiplicity in colonic tissue of 1,2-dimethylhydrazine-treated C57BL/6J mice by dietary flavone is associated with an increased expression of Krebs cycle enzymes
Carcinogenesis, July 1, 2007; 28(7): 1446 - 1454.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Vanamala, T. Leonardi, B. S. Patil, S. S. Taddeo, M. E. Murphy, L. M. Pike, R. S. Chapkin, J. R. Lupton, and N. D. Turner
Suppression of colon carcinogenesis by bioactive compounds in grapefruit
Carcinogenesis, June 1, 2006; 27(6): 1257 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. W.L. Ma, R. H. Finnell, L. A. Davidson, E. S. Callaway, O. Spiegelstein, J. A. Piedrahita, J. M. Salbaum, C. Kappen, B. R. Weeks, J. James, et al.
Folate Transport Gene Inactivation in Mice Increases Sensitivity to Colon Carcinogenesis
Cancer Res., February 1, 2005; 65(3): 887 - 897.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, W. Su, E. A. Thompson, M. Leitges, N. R. Murray, and A. P. Fields
Protein Kinase C{beta}II Regulates Its Own Expression in Rat Intestinal Epithelial Cells and the Colonic Epithelium in Vivo
J. Biol. Chem., October 29, 2004; 279(44): 45556 - 45563.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K.-i. Fujita, E. Matsuda, K. Sekine, M. Iigo, and H. Tsuda
Lactoferrin enhances Fas expression and apoptosis in the colon mucosa of azoxymethane-treated rats
Carcinogenesis, October 1, 2004; 25(10): 1961 - 1966.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A. P. Femia, P. Dolara, and G. Caderni
Mucin-depleted foci (MDF) in the colon of rats treated with azoxymethane (AOM) are useful biomarkers for colon carcinogenesis
Carcinogenesis, February 1, 2004; 25(2): 277 - 281.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Ochiai, M. Ushigome, K. Fujiwara, T. Ubagai, T. Kawamori, T. Sugimura, M. Nagao, and H. Nakagama
Characterization of Dysplastic Aberrant Crypt Foci in the Rat Colon Induced by 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine
Am. J. Pathol., October 1, 2003; 163(4): 1607 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Begleiter, K. Sivananthan, T. J. Curphey, and R. P. Bird
Induction of NAD(P)H Quinone: Oxidoreductase1 Inhibits Carcinogen-induced Aberrant Crypt Foci in Colons of Sprague-Dawley Rats
Cancer Epidemiol. Biomarkers Prev., June 1, 2003; 12(6): 566 - 572.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Caderni, A. P. Femia, A. Giannini, A. Favuzza, C. Luceri, M. Salvadori, and P. Dolara
Identification of Mucin-depleted Foci in the Unsectioned Colon of Azoxymethane-treated Rats: Correlation with Carcinogenesis
Cancer Res., May 15, 2003; 63(10): 2388 - 2392.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. K. Wali, S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, J. Hart, J. Wang, M. Wen, A. Ramaswamy, L. Joseph, et al.
Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1653 - 1662.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Gökmen-Polar, N. R. Murray, M. A. Velasco, Z. Gatalica, and A. P. Fields
Elevated Protein Kinase C {beta}II Is an Early Promotive Event in Colon Carcinogenesis
Cancer Res., February 1, 2001; 61(4): 1375 - 1381.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
M.V.W. Wijnands, H.C. Schoterman, J.P. Bruijntjes, V.M.H. Hollanders, and R.A. Woutersen
Effect of dietary galacto-oligosaccharides on azoxymethane-induced aberrant crypt foci and colorectal cancer in Fischer 344 rats
Carcinogenesis, January 1, 2001; 22(1): 127 - 132.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. J. Rijken, W. G. Timmer, A. J. van de Kooij, I. M. van Benschop, S. A. Wiseman, M. Meijers, and L. B.M. Tijburg
Effect of vegetable and carotenoid consumption on aberrant crypt multiplicity, a surrogate end-point marker for colorectal cancer in azoxymethane-induced rats
Carcinogenesis, December 1, 1999; 20(12): 2267 - 2272.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. M. Fenoglio-Preiser and A. Noffsinger
Review Article: Aberrant Crypt Foci: A Review
Toxicol Pathol, November 1, 1999; 27(6): 632 - 642.
[PDF]


Home page
CarcinogenesisHome page
M. J. Davies, E. A. Bowey, H. Adlercreutz, I. R. Rowland, and P. C. Rumsby
Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats
Carcinogenesis, June 1, 1999; 20(6): 927 - 931.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Ishizuka, S. Ito, M. Onuma, T. Kasai, Y. Aoyama, and H. Hara
Ingestion of sugar beet fiber enhances irradiation-induced aberrant crypt foci in the rat colon under an apoptosis-suppressed condition
Carcinogenesis, June 1, 1999; 20(6): 1005 - 1009.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Ishiguro, M. Ochiai, T. Sugimura, M. Nagao, and H. Nakagama
Strain differences of rats in the susceptibility to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo- [4,5-b]pyridine: no implication of Apc and Pla2g2a genetic polymorphisms in differential susceptibility
Carcinogenesis, June 1, 1999; 20(6): 1063 - 1068.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
N. R. Murray, L. A. Davidson, R. S. Chapkin, W. Clay Gustafson, D. G. Schattenberg, and A. P. Fields
Overexpression of Protein Kinase C beta II Induces Colonic Hyperproliferation and Increased Sensitivity to Colon Carcinogenesis
J. Cell Biol., May 17, 1999; 145(4): 699 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
T. P. Pretlow and T. G. Pretlow
Putative Preneoplastic Changes Identified by Enzyme Histochemical and Immunohistochemical Techniques
J. Histochem. Cytochem., May 1, 1998; 46(5): 577 - 584.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1993 by the American Association for Cancer Research.